Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating an Individualized Music Program Intervention in Long-term Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03174717
Recruitment Status : Not yet recruiting
First Posted : June 2, 2017
Last Update Posted : June 2, 2017
Sponsor:
Collaborators:
David Maggs
Jennifer Buckle
Veronica Hutchings
Kate Lafferty
David Tapp
Information provided by (Responsible Party):
Benjamin Zendel, Memorial University of Newfoundland

Brief Summary:
The goal of this study is to examine the impact of an individualized music program that includes music performance impacts quality of life, PRN drug use and scores on the RAI-MDS for residents of a long-term care facility. The impact of this program on staff at the long-term care facility and musicians performing at the facility will also be assessed.

Condition or disease Intervention/treatment Phase
Quality of Life Behavioral: Music performance Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Evaluating an Individualized Music Program Intervention in Long-term Care
Estimated Study Start Date : June 2017
Estimated Primary Completion Date : November 2017
Estimated Study Completion Date : November 2017

Arm Intervention/treatment
Experimental: Music intervention
LTC residents will participate in an individualized music performance with a musician
Behavioral: Music performance
residents of LTC will learn and perform songs with musicians from the community




Primary Outcome Measures :
  1. PRN drug use in LTC residents [ Time Frame: 12 weeks ]
  2. Behavioural assessments [ Time Frame: 12 weeks ]
    RAI-MDS

  3. Experience of LTC residents [ Time Frame: 12 weeks ]
    Qualitative assessment via interview with residents

  4. Experience of LTC staff [ Time Frame: 12 weeks ]
    Qualitative assessment via interview with staff

  5. Experience of Musicians [ Time Frame: 12 weeks ]
    Qualitative assessment via interview with musician



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Resident, staff at Bonne Bay LTC, or musician performing at the Bonne Bay LTC

Exclusion Criteria:

  • everyone else

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03174717


Contacts
Layout table for location contacts
Contact: Benjamin Zendel, PhD 709-639-4765 bzendel@mun.ca

Sponsors and Collaborators
Memorial University of Newfoundland
David Maggs
Jennifer Buckle
Veronica Hutchings
Kate Lafferty
David Tapp

Layout table for additonal information
Responsible Party: Benjamin Zendel, Canada Research Chair, Assistant Professor, Memorial University of Newfoundland
ClinicalTrials.gov Identifier: NCT03174717     History of Changes
Other Study ID Numbers: LTCMusic
First Posted: June 2, 2017    Key Record Dates
Last Update Posted: June 2, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No